Leo Pallanck - Publications

Affiliations: 
University of Washington, Seattle, Seattle, WA 

46 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Vincow ES, Thomas RE, Milstein G, Pareek G, Bammler T, MacDonald J, Pallanck L. Glucocerebrosidase deficiency leads to neuropathology via cellular immune activation. Biorxiv : the Preprint Server For Biology. PMID 38168223 DOI: 10.1101/2023.12.13.571406  0.776
2021 Jewett KA, Thomas RE, Phan CQ, Lin B, Milstein G, Yu S, Bettcher LF, Neto FC, Djukovic D, Raftery D, Pallanck LJ, Davis MY. Glucocerebrosidase reduces the spread of protein aggregation in a Drosophila melanogaster model of neurodegeneration by regulating proteins trafficked by extracellular vesicles. Plos Genetics. 17: e1008859. PMID 33539341 DOI: 10.1371/journal.pgen.1008859  0.333
2021 Vincow ES, Thomas RE, Merrihew GE, MacCoss MJ, Pallanck LJ. Slowed protein turnover in aging Drosophila reflects a shift in cellular priorities. The Journals of Gerontology. Series a, Biological Sciences and Medical Sciences. PMID 33453098 DOI: 10.1093/gerona/glab015  0.776
2020 Pareek G, Pallanck LJ. Inactivation of the mitochondrial protease Afg3l2 results in severely diminished respiratory chain activity and widespread defects in mitochondrial gene expression. Plos Genetics. 16: e1009118. PMID 33075064 DOI: 10.1371/journal.pgen.1009118  0.407
2019 Andreazza S, Samstag CL, Sanchez-Martinez A, Fernandez-Vizarra E, Gomez-Duran A, Lee JJ, Tufi R, Hipp MJ, Schmidt EK, Nicholls TJ, Gammage PA, Chinnery PF, Minczuk M, Pallanck LJ, Kennedy SR, et al. Mitochondrially-targeted APOBEC1 is a potent mtDNA mutator affecting mitochondrial function and organismal fitness in Drosophila. Nature Communications. 10: 3280. PMID 31337756 DOI: 10.1038/S41467-019-10857-Y  0.601
2019 Vincow ES, Thomas RE, Merrihew G, Shulman NJ, Bammler TK, MacDonald JW, MacCoss MJ, Pallanck LJ. Autophagy accounts for approximately one-third of mitochondrial protein turnover and is protein selective. Autophagy. PMID 30865561 DOI: 10.1080/15548627.2019.1586258  0.785
2018 Pareek G, Pallanck LJ. Inactivation of Lon protease reveals a link between mitochondrial unfolded protein stress and mitochondrial translation inhibition. Cell Death & Disease. 9: 1168. PMID 30518747 DOI: 10.1038/s41419-018-1213-6  0.319
2018 Pareek G, Thomas RE, Vincow ES, Morris DR, Pallanck LJ. Lon protease inactivation in causes unfolded protein stress and inhibition of mitochondrial translation. Cell Death Discovery. 5: 51. PMID 30374414 DOI: 10.1038/S41420-018-0110-1  0.792
2018 Thomas RE, Vincow ES, Merrihew GE, MacCoss MJ, Davis MY, Pallanck LJ. Glucocerebrosidase deficiency promotes protein aggregation through dysregulation of extracellular vesicles. Plos Genetics. 14: e1007694. PMID 30256786 DOI: 10.1371/Journal.Pgen.1007694  0.811
2018 Pareek G, Thomas RE, Pallanck LJ. Loss of the Drosophila m-AAA mitochondrial protease paraplegin results in mitochondrial dysfunction, shortened lifespan, and neuronal and muscular degeneration. Cell Death & Disease. 9: 304. PMID 29467464 DOI: 10.1038/s41419-018-0365-8  0.401
2017 Whitworth AJ, Pallanck LJ. PINK1/Parkin mitophagy and neurodegeneration-what do we really know in vivo? Current Opinion in Genetics & Development. 44: 47-53. PMID 28213158 DOI: 10.1016/j.gde.2017.01.016  0.549
2014 Thomas RE, Andrews LA, Burman JL, Lin WY, Pallanck LJ. PINK1-Parkin pathway activity is regulated by degradation of PINK1 in the mitochondrial matrix. Plos Genetics. 10: e1004279. PMID 24874806 DOI: 10.1371/journal.pgen.1004279  0.339
2013 Pallanck L. Mitophagy: mitofusin recruits a mitochondrial killer. Current Biology : Cb. 23: R570-2. PMID 23845246 DOI: 10.1016/j.cub.2013.05.032  0.389
2013 Vincow ES, Merrihew G, Thomas RE, Shulman NJ, Beyer RP, MacCoss MJ, Pallanck LJ. The PINK1-Parkin pathway promotes both mitophagy and selective respiratory chain turnover in vivo. Proceedings of the National Academy of Sciences of the United States of America. 110: 6400-5. PMID 23509287 DOI: 10.1073/Pnas.1221132110  0.8
2013 Kim NC, Tresse E, Kolaitis RM, Molliex A, Thomas RE, Alami NH, Wang B, Joshi A, Smith RB, Ritson GP, Winborn BJ, Moore J, Lee JY, Yao TP, Pallanck L, et al. VCP is essential for mitochondrial quality control by PINK1/Parkin and this function is impaired by VCP mutations. Neuron. 78: 65-80. PMID 23498974 DOI: 10.1016/J.Neuron.2013.02.029  0.465
2012 Hsieh EJ, Shulman NJ, Dai DF, Vincow ES, Karunadharma PP, Pallanck L, Rabinovitch PS, MacCoss MJ. Topograph, a software platform for precursor enrichment corrected global protein turnover measurements. Molecular & Cellular Proteomics : McP. 11: 1468-74. PMID 22865922 DOI: 10.1074/Mcp.O112.017699  0.766
2012 Burman JL, Yu S, Poole AC, Decal RB, Pallanck L. Analysis of neural subtypes reveals selective mitochondrial dysfunction in dopaminergic neurons from parkin mutants. Proceedings of the National Academy of Sciences of the United States of America. 109: 10438-43. PMID 22691499 DOI: 10.1073/Pnas.1120688109  0.737
2010 Chakrabarti L, Zahra R, Jackson SM, Kazemi-Esfarjani P, Sopher BL, Mason AG, Toneff T, Ryu S, Shaffer S, Kansy JW, Eng J, Merrihew G, MacCoss MJ, Murphy A, Goodlett DR, ... ... Pallanck LJ, et al. Mitochondrial dysfunction in NnaD mutant flies and Purkinje cell degeneration mice reveals a role for Nna proteins in neuronal bioenergetics. Neuron. 66: 835-47. PMID 20620870 DOI: 10.1016/J.Neuron.2010.05.024  0.332
2010 Poole AC, Thomas RE, Yu S, Vincow ES, Pallanck L. The mitochondrial fusion-promoting factor mitofusin is a substrate of the PINK1/parkin pathway. Plos One. 5: e10054. PMID 20383334 DOI: 10.1371/Journal.Pone.0010054  0.777
2009 Whitworth AJ, Pallanck LJ. The PINK1/Parkin pathway: a mitochondrial quality control system? Journal of Bioenergetics and Biomembranes. 41: 499-503. PMID 19967438 DOI: 10.1007/s10863-009-9253-3  0.586
2008 Whitworth AJ, Pallanck LJ. Genetic models of Parkinson's disease: mechanisms and therapies. Seb Experimental Biology Series. 60: 93-113. PMID 18309789  0.438
2008 Poole AC, Thomas RE, Andrews LA, McBride HM, Whitworth AJ, Pallanck LJ. The PINK1/Parkin pathway regulates mitochondrial morphology. Proceedings of the National Academy of Sciences of the United States of America. 105: 1638-43. PMID 18230723 DOI: 10.1073/Pnas.0709336105  0.781
2007 Voght SP, Fluegel ML, Andrews LA, Pallanck LJ. Drosophila NPC1b promotes an early step in sterol absorption from the midgut epithelium. Cell Metabolism. 5: 195-205. PMID 17339027 DOI: 10.1016/J.Cmet.2007.01.011  0.657
2006 Satterfield TF, Pallanck LJ. Ataxin-2 and its Drosophila homolog, ATX2, physically assemble with polyribosomes. Human Molecular Genetics. 15: 2523-32. PMID 16835262 DOI: 10.1093/hmg/ddl173  0.684
2006 Pallanck L, Greenamyre JT. Neurodegenerative disease: pink, parkin and the brain. Nature. 441: 1058. PMID 16810237 DOI: 10.1038/4411058a  0.374
2006 Whitworth AJ, Wes PD, Pallanck LJ. Drosophila models pioneer a new approach to drug discovery for Parkinson's disease. Drug Discovery Today. 11: 119-26. PMID 16533709 DOI: 10.1016/S1359-6446(05)03693-7  0.48
2006 Fluegel ML, Parker TJ, Pallanck LJ. Mutations of a Drosophila NPC1 gene confer sterol and ecdysone metabolic defects. Genetics. 172: 185-96. PMID 16079224 DOI: 10.1534/Genetics.105.046565  0.776
2005 Meulener M, Whitworth AJ, Armstrong-Gold CE, Rizzu P, Heutink P, Wes PD, Pallanck LJ, Bonini NM. Drosophila DJ-1 mutants are selectively sensitive to environmental toxins associated with Parkinson's disease. Current Biology : Cb. 15: 1572-7. PMID 16139213 DOI: 10.1016/J.Cub.2005.07.064  0.499
2005 Whitworth AJ, Theodore DA, Greene JC, Benes H, Wes PD, Pallanck LJ. Increased glutathione S-transferase activity rescues dopaminergic neuron loss in a Drosophila model of Parkinson's disease. Proceedings of the National Academy of Sciences of the United States of America. 102: 8024-9. PMID 15911761 DOI: 10.1073/Pnas.0501078102  0.555
2005 Jackson SM, Whitworth AJ, Greene JC, Libby RT, Baccam SL, Pallanck LJ, La Spada AR. A SCA7 CAG/CTG repeat expansion is stable in Drosophila melanogaster despite modulation of genomic context and gene dosage. Gene. 347: 35-41. PMID 15715978 DOI: 10.1016/j.gene.2004.12.008  0.524
2005 Greene JC, Whitworth AJ, Andrews LA, Parker TJ, Pallanck LJ. Genetic and genomic studies of Drosophila parkin mutants implicate oxidative stress and innate immune responses in pathogenesis. Human Molecular Genetics. 14: 799-811. PMID 15689351 DOI: 10.1093/hmg/ddi074  0.587
2005 Pallanck LJ, Whitworth AJ. Drosophila models of parkinson disease Movement Disorders. 173-182. DOI: 10.1016/B978-012088382-0/50014-1  0.445
2004 Babcock M, Macleod GT, Leither J, Pallanck L. Genetic analysis of soluble N-ethylmaleimide-sensitive factor attachment protein function in Drosophila reveals positive and negative secretory roles. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 24: 3964-73. PMID 15102912 DOI: 10.1523/Jneurosci.5259-03.2004  0.774
2003 Babcock MC, Stowers RS, Leither J, Goodman CS, Pallanck LJ. A genetic screen for synaptic transmission mutants mapping to the right arm of chromosome 3 in Drosophila. Genetics. 165: 171-83. PMID 14504225  0.735
2003 Greene JC, Whitworth AJ, Kuo I, Andrews LA, Feany MB, Pallanck LJ. Mitochondrial pathology and apoptotic muscle degeneration in Drosophila parkin mutants. Proceedings of the National Academy of Sciences of the United States of America. 100: 4078-83. PMID 12642658 DOI: 10.1073/Pnas.0737556100  0.6
2002 Satterfield TF, Jackson SM, Pallanck LJ. A Drosophila homolog of the polyglutamine disease gene SCA2 is a dosage-sensitive regulator of actin filament formation. Genetics. 162: 1687-702. PMID 12524342  0.694
2001 Golby JA, Tolar LA, Pallanck L. Partitioning of N-ethylmaleimide-sensitive fusion (NSF) protein function in Drosophila melanogaster: dNSF1 is required in the nervous system, and dNSF2 is required in mesoderm. Genetics. 158: 265-78. PMID 11333235  0.803
1999 Littleton JT, Pallanck L, Ganetzky B. Mechanisms of neurotransmitter release. International Review of Neurobiology. 43: 139-61. PMID 10218158  0.471
1998 Tolar LA, Pallanck L. NSF function in neurotransmitter release involves rearrangement of the SNARE complex downstream of synaptic vesicle docking. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 18: 10250-6. PMID 9852562 DOI: 10.1523/Jneurosci.18-24-10250.1998  0.353
1995 McManus OB, Helms LM, Pallanck L, Ganetzky B, Swanson R, Leonard RJ. Functional role of the beta subunit of high conductance calcium-activated potassium channels. Neuron. 14: 645-50. PMID 7695911 DOI: 10.1016/0896-6273(95)90321-6  0.493
1995 Ganetzky B, Warmke JW, Robertson G, Pallanck L. New potassium channel gene families in flies and mammals: from mutants to molecules. Society of General Physiologists Series. 50: 29-39. PMID 7676322  0.763
1995 Pallanck L, Ordway RW, Ramaswami M, Chi WY, Krishnan KS, Ganetzky B. Distinct roles for N-ethylmaleimide-sensitive fusion protein (NSF) suggested by the identification of a second Drosophila NSF homolog. The Journal of Biological Chemistry. 270: 18742-4. PMID 7642522 DOI: 10.1074/Jbc.270.32.18742  0.766
1995 Pallanck L, Ordway RW, Ganetzky B. A Drosophila NSF mutant. Nature. 376: 25. PMID 7596428 DOI: 10.1038/376025a0  0.768
1994 Ordway RW, Pallanck L, Ganetzky B. Neurally expressed Drosophila genes encoding homologs of the NSF and SNAP secretory proteins. Proceedings of the National Academy of Sciences of the United States of America. 91: 5715-9. PMID 8202553 DOI: 10.1073/pnas.91.12.5715  0.784
1994 Pallanck L, Ganetzky B. Cloning and characterization of human and mouse homologs of the Drosophila calcium-activated potassium channel gene, slowpoke. Human Molecular Genetics. 3: 1239-43. PMID 7987297 DOI: 10.1093/Hmg/3.8.1239  0.529
1994 Ordway RW, Pallanck L, Ganetzky B. A TPR domain in the SNAP secretory proteins. Trends in Biochemical Sciences. 19: 530-1. PMID 7846761 DOI: 10.1016/0968-0004(94)90052-3  0.728
Show low-probability matches.